DCT
1:21-cv-01338
Puma Biotechnology Inc v. AstraZeneca Pharma LP
General
Cause of ActionPatent Infringement
SectorBiotech
Status
Closed (08/21/24)
Patent Owner
Operating Company (L)
PACER
1:21-cv-01338
Nature of Suit830 Patent
Appeals
CourtD. Delaware
| Judge | Period | PO Win Rate | 
|---|---|---|
| 02/01/22 - 09/17/24 | 61% | |
| 11/16/21 - 02/01/22 | 43% | 
MagistrateMary Pat Thynge
Plaintiff
Attorney
| Name | Ratings | 
|---|---|
| L5 A | |
| L4 B | |
| L4 C | |
| L4 C | |
| L3 A | |
| L3 E | |
| L3 E | |
| L2 B | |
| L1 C | |
| L1 C | |
| L1 D | |
| L1 E | |
| -- -- -- | |
| -- -- -- | |
| -- -- -- | |
| -- -- -- | |
| -- -- -- | |
| -- -- -- | |
| L5 A | |
| L5 A | |
| L5 A | |
| L5 A | |
| L3 E | |
| L3 B | |
| L3 E | |
| L1 E | |
| -- -- -- | 
No Attorneys
Defendant
Party
| Name | Ratings | 
|---|---|
| L5 A | |
| L5 A | |
| L5 A | 
No Parties
Attorney
| Name | Ratings | 
|---|---|
| Shaw Keller LLPLocal | L5 D | 
| L5 A | |
| L5 E | |
| L2 B | |
| L4 B | |
| L5 D | |
| L4 B | |
| L3 A | |
| L3 C | |
| L3 D | |
| L1 B | |
| L1 C | |
| L1 C | |
| -- -- -- | |
| -- -- -- | |
| -- -- -- | |
| -- -- -- | |
| -- -- -- | 
No Attorneys